(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide

C60H70ClN13O6S — CID 158943224

IUPAC(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide
SMILESCCC(O)(CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1)c1ccccc1.CCC(O)(CC(=O)Nc1nc2cccnc2n1C1CCC1)c1ccccc1.Cc1ccc2nc(NC(=O)C[C@](C)(O)c3nccs3)n(C(C)(C)C)c2n1
InChIInChI=1S/C21H23ClN4O2.C21H24N4O2.C18H23N5O2S/c1-2-21(28,14-7-4-3-5-8-14)13-18(27)25-20-23-16-11-12-17(22)24-19(16)26(20)15-9-6-10-15;1-2-21(27,15-8-4-3-5-9-15)14-18(26)24-20-23-17-12-7-13-22-19(17)25(20)16-10-6-11-16;1-11-6-7-12-14(20-11)23(17(2,3)4)16(21-12)22-13(24)10-18(5,25)15-19-8-9-26-15/h3-5,7-8,11-12,15,28H,2,6,9-10,13H2,1H3,(H,23,25,27);3-5,7-9,12-13,16,27H,2,6,10-11,14H2,1H3,(H,23,24,26);6-9,25H,10H2,1-5H3,(H,21,22,24)/t;;18-/m..0/s1
InChIKeyJKMXJTQMMLQIAN-BVWZTCPQSA-N
MW1136.82 g/mol
LogP11.41
Rot. Bonds16

About (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide

(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide (PubChem CID 158943224) has the molecular formula C60H70ClN13O6S and a molecular weight of 1136.82 g/mol. Its IUPAC name is (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide.

Molecular Properties

Compound Name(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide
PubChem CID158943224
Molecular FormulaC60H70ClN13O6S
Molecular Weight1136.82 g/mol
Exact Mass1135.50
IUPAC Name(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide
SMILESCCC(O)(CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1)c1ccccc1.CCC(O)(CC(=O)Nc1nc2cccnc2n1C1CCC1)c1ccccc1.Cc1ccc2nc(NC(=O)C[C@](C)(O)c3nccs3)n(C(C)(C)C)c2n1
InChIInChI=1S/C21H23ClN4O2.C21H24N4O2.C18H23N5O2S/c1-2-21(28,14-7-4-3-5-8-14)13-18(27)25-20-23-16-11-12-17(22)24-19(16)26(20)15-9-6-10-15;1-2-21(27,15-8-4-3-5-9-15)14-18(26)24-20-23-17-12-7-13-22-19(17)25(20)16-10-6-11-16;1-11-6-7-12-14(20-11)23(17(2,3)4)16(21-12)22-13(24)10-18(5,25)15-19-8-9-26-15/h3-5,7-8,11-12,15,28H,2,6,9-10,13H2,1H3,(H,23,25,27);3-5,7-9,12-13,16,27H,2,6,10-11,14H2,1H3,(H,23,24,26);6-9,25H,10H2,1-5H3,(H,21,22,24)/t;;18-/m..0/s1
InChIKeyJKMXJTQMMLQIAN-BVWZTCPQSA-N
XLogP11.41
TPSA253.01 Ų
H-Bond Donors6
H-Bond Acceptors17
Rotatable Bonds16
Heavy Atoms81
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001136.82
LogP ≤ 511.41
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide?
The IUPAC name of (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide (CID 158943224) is (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide.
What is the SMILES notation for (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide?
The canonical SMILES for (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide is CCC(O)(CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1)c1ccccc1.CCC(O)(CC(=O)Nc1nc2cccnc2n1C1CCC1)c1ccccc1.Cc1ccc2nc(NC(=O)C[C@](C)(O)c3nccs3)n(C(C)(C)C)c2n1.
What is the InChIKey of (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide?
The InChIKey is JKMXJTQMMLQIAN-BVWZTCPQSA-N. The full InChI is InChI=1S/C21H23ClN4O2.C21H24N4O2.C18H23N5O2S/c1-2-21(28,14-7-4-3-5-8-14)13-18(27)25-20-23-16-11-12-17(22)24-19(16)26(20)15-9-6-10-15;1-2-21(27,15-8-4-3-5-9-15)14-18(26)24-20-23-17-12-7-13-22-19(17)25(20)16-10-6-11-16;1-11-6-7-12-14(20-11)23(17(2,3)4)16(21-12)22-13(24)10-18(5,25)15-19-8-9-26-15/h3-5,7-8,11-12,15,28H,2,6,9-10,13H2,1H3,(H,23,25,27);3-5,7-9,12-13,16,27H,2,6,10-11,14H2,1H3,(H,23,24,26);6-9,25H,10H2,1-5H3,(H,21,22,24)/t;;18-/m..0/s1.
What are the key properties of (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide?
(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide has a molecular weight of 1136.82 g/mol, XLogP of 11.41, 16 rotatable bonds, 6 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide is sourced from PubChem (CID 158943224), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).